year_month;area;week;week_long;tos;atc_1_lvl;atc_1_lvl_desc;atc_2_lvl;atc_2_lvl_desc;atc_3_lvl;atc_3_lvl_desc;atc_4_lvl;atc_4_lvl_desc;atc_5_lvl;atc_5_lvl_desc;pack_code;pack_descr;product_descr;product_manufacturer;pack_product_manufacturer;tot_qty2015-4;Athens Metropolitan Area;14;14w (30/3-5/4);P;J;ANTIINFECTIVES FOR SYSTEMIC USE;J01;ANTIBACTERIALS FOR SYSTEMIC USE;J01X;OTHER ANTIBACTERIALS;J01XA;Glycopeptide antibacterials;J01XA01;vancomycin;2801788502018;VONCON PD.SOL.INF 1X500MG VIAL;VONCON;VONCON   (FARMASERB LILLY A.E.B.E.);FARMASERB LILLY A.E.B.E.;10
2015-4;Thessaly, Epirus and Corfu including southeastern Grevena;17;17w (20/4-26/4);C;C;CARDIOVASCULAR SYSTEM;C07;BETA BLOCKING AGENTS;C07A;BETA BLOCKING AGENTS;C07AG;Alpha and beta blocking agents;C07AG02;carvedilol;2802623602016;CARVEPEN TABL BTX28X6,25MG;CARVEPEN;CARVEPEN   (ELPEN AE FARMAKEYTIKH BIOMHXANIA);ELPEN AE FARMAKEYTIKH BIOMHXANIA;2
2015-4;Central, Northwestern, Western and Southern Macedonia excluding southeastern Grevena;18;18w (27/4-3/5);C;C;CARDIOVASCULAR SYSTEM;C09;AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A;ACE INHIBITORS, PLAIN;C09AA;ACE inhibitors, plain;C09AA04;perindopril;2801971905053;COVERSYL F.C.TAB 5MG/TAB BTx30 σε BLISTER;COVERSYL;COVERSYL   (SERBIE ELLAS FARMAKEYTIKH E.P.E.);SERBIE ELLAS FARMAKEYTIKH E.P.E.;4
2015-5;Central, Northwestern, Western and Southern Macedonia excluding southeastern Grevena;19;19w (4/5-10/5);P;B;BLOOD AND BLOOD FORMING ORGANS;B01;ANTITHROMBOTIC AGENTS;B01A;ANTITHROMBOTIC AGENTS;B01AB;Heparin group;B01AB10;tinzaparin;2802016809022;INNOHEP PF.SYR 10X0,5ML 10.000AXA;INNOHEP;INNOHEP   (LEO FARMAKEYTIKH ELLAS ANONYMH ETAIREIA D.T. LEO FARMAKEYTIKH ELLAS AE & LEO PHARMACEUTICAL HELLAS SA);LEO FARMAKEYTIKH ELLAS ANONYMH ETAIREIA D.T. LEO FARMAKEYTIKH ELLAS AE & LEO PHARMACEUTICAL HELLAS SA;4
2015-4;Central, Northwestern, Western and Southern Macedonia excluding southeastern Grevena;17;17w (20/4-26/4);P;C;CARDIOVASCULAR SYSTEM;C08;CALCIUM CHANNEL BLOCKERS;C08C;SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA;Dihydropyridine derivatives;C08CA01;amlodipine;2802818801057;AMLIBON BES TABL X30 AL/PVC 5MG;AMLIBON;AMLIBON   (SANDOZ GMBH, KUNDL, AUSTRIA);SANDOZ GMBH, KUNDL, AUSTRIA;1